drugset / Trial / NCT00108264
Tumor RNA Transfected Dendritic Cell Vaccines
Non-randomizedSingle-groupOpen-label
Summary
The purpose of this study is to use dendritic cells transfected with amplified RNA from autologous tumor cells to develop a vaccine strategy for the treatment of prostate cancer in patients with disseminated disease.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tumor RNA transfected dendritic cells | Cell therapy | — | — |